Mechanism of Action
RNA Replicase Inhibitors
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Clinical Trials (5)
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis
Loss of Exclusivity
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 9085573 | Mar 21, 2028 | SubstanceProduct | U-1470 |
| 8334270 | Mar 21, 2028 | SubstanceProduct | U-1470 |
| 8580765 | Mar 21, 2028 | SubstanceProduct | U-1470 |
| 9085573*PED | Sep 21, 2028 | — | |
| 8334270*PED | Sep 21, 2028 | — |